224 related articles for article (PubMed ID: 18245144)
1. Characterisation of the range of neutrophil stimulating mediators in cystic fibrosis sputum.
Mackerness KJ; Jenkins GR; Bush A; Jose PJ
Thorax; 2008 Jul; 63(7):614-20. PubMed ID: 18245144
[TBL] [Abstract][Full Text] [Related]
2. Production of the potent neutrophil chemokine, growth-related protein alpha (GROalpha), is not elevated in cystic fibrosis children.
Wyatt HA; Sampson AP; Balfour-Lynn IM; Price JF
Respir Med; 2000 Feb; 94(2):106-11. PubMed ID: 10714414
[TBL] [Abstract][Full Text] [Related]
3. Downmodulation of CXCL8/IL-8 receptors on neutrophils after recruitment in the airways.
Pignatti P; Moscato G; Casarini S; Delmastro M; Poppa M; Brunetti G; Pisati P; Balbi B
J Allergy Clin Immunol; 2005 Jan; 115(1):88-94. PubMed ID: 15637552
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers of neutrophilic inflammation in exhaled air of cystic fibrosis children with bacterial airway infections.
Bodini A; D'Orazio C; Peroni D; Corradi M; Folesani G; Baraldi E; Assael BM; Boner A; Piacentini GL
Pediatr Pulmonol; 2005 Dec; 40(6):494-9. PubMed ID: 16229003
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a novel chemotactic factor for neutrophils in the bronchial secretions of patients with cystic fibrosis.
Dudez TS; Chanson M; Schlegel-Haueter SE; Suter S
J Infect Dis; 2002 Sep; 186(6):774-81. PubMed ID: 12198611
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil cell death, activation and bacterial infection in cystic fibrosis.
Watt AP; Courtney J; Moore J; Ennis M; Elborn JS
Thorax; 2005 Aug; 60(8):659-64. PubMed ID: 16061707
[TBL] [Abstract][Full Text] [Related]
7. Induced sputum in cystic fibrosis: within-week reproducibility of inflammatory markers.
Smountas AA; Lands LC; Mohammed SR; Grey V
Clin Biochem; 2004 Nov; 37(11):1031-6. PubMed ID: 15498533
[TBL] [Abstract][Full Text] [Related]
8. Withdrawal of inhaled steroids in children with non-cystic fibrosis bronchiectasis.
Guran T; Ersu R; Karadag B; Karakoc F; Demirel GY; Hekim N; Dagli E
J Clin Pharm Ther; 2008 Dec; 33(6):603-11. PubMed ID: 19138237
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress and lipid-derived inflammatory mediators during acute exacerbations of cystic fibrosis.
Reid DW; Misso N; Aggarwal S; Thompson PJ; Walters EH
Respirology; 2007 Jan; 12(1):63-9. PubMed ID: 17207027
[TBL] [Abstract][Full Text] [Related]
10. Human leukocyte elastase and cathepsin G are specific inhibitors of C5a-dependent neutrophil enzyme release and chemotaxis.
Tralau T; Meyer-Hoffert U; Schröder JM; Wiedow O
Exp Dermatol; 2004 May; 13(5):316-25. PubMed ID: 15140022
[TBL] [Abstract][Full Text] [Related]
11. Comparison of sputum processing techniques in cystic fibrosis.
Cai Y; Carty K; Gibson P; Henry R
Pediatr Pulmonol; 1996 Dec; 22(6):402-7. PubMed ID: 9016474
[TBL] [Abstract][Full Text] [Related]
12. Peroxidase activity within circulating neutrophils correlates with pulmonary phenotype in cystic fibrosis.
Garner HP; Phillips JR; Herron JG; Severson SJ; Milla CE; Regelmann WE
J Lab Clin Med; 2004 Sep; 144(3):127-33. PubMed ID: 15454881
[TBL] [Abstract][Full Text] [Related]
13. The effect of treatment of cystic fibrosis pulmonary exacerbations on airways and systemic inflammation.
Downey DG; Brockbank S; Martin SL; Ennis M; Elborn JS
Pediatr Pulmonol; 2007 Aug; 42(8):729-35. PubMed ID: 17588254
[TBL] [Abstract][Full Text] [Related]
14. Nebulized hypertonic saline decreases IL-8 in sputum of patients with cystic fibrosis.
Reeves EP; Williamson M; O'Neill SJ; Greally P; McElvaney NG
Am J Respir Crit Care Med; 2011 Jun; 183(11):1517-23. PubMed ID: 21330456
[TBL] [Abstract][Full Text] [Related]
15. Impaired neutrophil chemotaxis in chronic obstructive pulmonary disease.
Yoshikawa T; Dent G; Ward J; Angco G; Nong G; Nomura N; Hirata K; Djukanovic R
Am J Respir Crit Care Med; 2007 Mar; 175(5):473-9. PubMed ID: 17110644
[TBL] [Abstract][Full Text] [Related]
16. Prolastin aerosol therapy and sputum taurine in cystic fibrosis.
Cantin AM; Berthiaume Y; Cloutier D; Martel M
Clin Invest Med; 2006 Aug; 29(4):201-7. PubMed ID: 16986483
[TBL] [Abstract][Full Text] [Related]
17. Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity.
Fick RB; Robbins RA; Squier SU; Schoderbek WE; Russ WD
Pediatr Res; 1986 Dec; 20(12):1258-68. PubMed ID: 3540828
[TBL] [Abstract][Full Text] [Related]
18. Monocyte chemoattractant chemokines in cystic fibrosis.
Rao S; Wright AK; Montiero W; Ziegler-Heitbrock L; Grigg J
J Cyst Fibros; 2009 Mar; 8(2):97-103. PubMed ID: 19000946
[TBL] [Abstract][Full Text] [Related]
19. Induced sputum inflammatory measures correlate with lung function in children with cystic fibrosis.
Sagel SD; Sontag MK; Wagener JS; Kapsner RK; Osberg I; Accurso FJ
J Pediatr; 2002 Dec; 141(6):811-7. PubMed ID: 12461498
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil recruitment and airway epithelial cell involvement in chronic cystic fibrosis lung disease.
Conese M; Copreni E; Di Gioia S; De Rinaldis P; Fumarulo R
J Cyst Fibros; 2003 Sep; 2(3):129-35. PubMed ID: 15463861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
